cytarabine has been researched along with Anemia in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (51.16) | 18.7374 |
| 1990's | 6 (13.95) | 18.2507 |
| 2000's | 6 (13.95) | 29.6817 |
| 2010's | 6 (13.95) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, G; Cortes, JE; DiRienzo, CG; Dombret, H; Jeyakumar, D; Jou, E; Liu, X; Ma, W; Mayer, J; Merchant, A; Montesinos, P; Novak, J; O'Brien, T; Robak, T; Roh, W; Sekeres, MA; Shaik, N; Taussig, DC; Tomlinson, B; Wang, J | 1 |
| Bakare, BY; Bello, FO; Ojo, OT; Olatunji, AO; Olatunji, PO | 1 |
| Bomalaski, JS; Chen, TY; Cho, SF; Feng, X; Hsiao, HH; Hsu, YT; Johnston, A; Kao, HW; Kuo, MC; Liu, TC; Liu, YC; Tsai, HJ | 1 |
| Chan, JY; Chang, EWY; Farid, M; Khoo, LP; Lim, ST; Poon, E; Somasundaram, N; Tang, TPL; Tao, M; Yang, VS; Yang, X | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Basavarajegowda, A; Das, S; Jafa, E; Kayal, S; Kumar, V | 1 |
| Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E | 1 |
| Huh, J; Kim, BS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Suh, C | 1 |
| Allard, C; Berger, M; Berthou, C; Coiteux, V; Corm, S; Delmer, A; Eclache, V; Etienne, G; Gardembas, M; Guerci-Bresler, A; Guilhot, F; Guilhot, J; Jourdan, E; Legros, L; Mahon, FX; Maloisel, F; Nicolini, FE; Preudhomme, C; Rea, D; Rigal-Huguet, F; Roche-Lestienne, C; Rousselot, P; Vekhoff, A | 1 |
| Endo, Y; Iwanaga, T; Miura, N; Miyoshi, N; Momoi, Y | 1 |
| Belleri, M; Presta, M; Ribatti, D; Vacca, A | 1 |
| Barjas-Castro, ML; Carvalho, MA; Castro, V; Gilli, SO; Locatelli, MF | 1 |
| Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P | 1 |
| Virgolini, L | 1 |
| Kubota, K; Mizoguchi, H; Nomura, Y; Okada, M | 1 |
| Baccarani, M; Bandini, G; Cavazzini, G; Fanin, R; Tura, S; Zaccaria, A | 1 |
| Cook, PA; Greenberg, HM; Hartwell, BL; Page, PL; Robinson, SH | 1 |
| Dabich, L | 1 |
| Kocsis, JJ; Lee, EW; Snyder, R | 1 |
| Braunschweiger, PG; Schenken, LL; Schiffer, LM | 1 |
| Fujisawa, S; Kanamori, H; Kodama, F; Maruta, A; Noguchi, T; Ogawa, K; Okubo, T; Sakai, R; Taguchi, J; Tomita, N | 1 |
| Lot, TY; Onwukeme, KE | 1 |
| Damon, LE; Linker, CA; Ries, CA; Rugo, HS | 1 |
| Aul, C; Germing, U; Giagounidis, AA; Giagounidis, AS; Koch, JA | 1 |
| Bueno, J; Julià, A; Villalba, T; Zuazu, J | 1 |
| Ascari, E; Avanzini, P; Baldini, L; Broglia, C; Ghirardelli, ML; Gobbi, PG; Loni, C; Quarta, G; Silingardi, V; Stelitano, C | 1 |
| Abruzzese, E; Amadori, S; Buccisano, F; Cox, MC; Del Poeta, G; Masi, M; Maurillo, L; Scimò, MT; Tamburini, A; Tribalto, M; Venditti, A | 1 |
| Bagby, GC; Richert-Boe, KE | 1 |
| Dunning, AJ | 1 |
| Cotes, PM; Hellebostad, M; Marstrander, J; Refsum, HE; Slørdahl, SH | 1 |
| Galanello, R; Papayannopoulou, T; Stamatoyannopoulos, G; Veith, R | 1 |
| Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL | 1 |
| Colebatch, JH; Matthews, RN | 1 |
| Garg, SK; Silber, R | 1 |
| Hamblin, TJ; Jones, JV | 1 |
| Bodey, GP; Bonnet, JD; Coltman, CA; Freireich, EJ; Gehan, EA; Haut, AB; Hewlett, JS; McCredit, KB; Saiki, JH; Wilson, HE | 1 |
| Armentrout, SA; Burns, CP | 1 |
| Basch, A; d'Oliveira, JG; Dreyfus, B; Gorius, JB; Sultan, C | 1 |
| Fischer, JJ; Papac, RJ | 1 |
| Lee, SL; Rosner, F | 1 |
| Armata, J; Cyklis, R; Garwicz, S; Halikowski, B; Wyszkowski, J | 1 |
| Lamerton, LF | 1 |
3 review(s) available for cytarabine and Anemia
| Article | Year |
|---|---|
[Acute promyelocytic leukemia. Review of the literature].
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia; Antibiotics, Antineoplastic; Child; Child, Preschool; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Heparin; Humans; Inclusion Bodies; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Neoplastic Stem Cells; Thioguanine; Translocation, Genetic | 1984 |
Adult acute nonlymphocytic leukemias.
Topics: Acute Disease; Aged; Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Blood Transfusion; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Drug Resistance; Female; Hemorrhage; Humans; Immunotherapy; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Transfusion; Spinal Cord; Syndrome | 1980 |
The use of ferrokinetics in the study of experimental anemia.
Topics: Anemia; Animals; Benzene; Cytarabine; Erythropoiesis; Hematopoietic Stem Cells; Humans; Hydroxyurea; Iron; Iron Radioisotopes; Kinetics; Pentobarbital | 1981 |
9 trial(s) available for cytarabine and Anemia
| Article | Year |
|---|---|
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Nausea | 2023 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Cytarabine; Drug Administration Schedule; Female; Humans; Hydrolases; Injections, Intramuscular; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Polyethylene Glycols; Thrombocytopenia; Treatment Outcome | 2021 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom | 2016 |
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study.
Topics: Adult; Alemtuzumab; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukopenia; Longitudinal Studies; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prospective Studies; Recurrence; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thrombocytopenia; Treatment Outcome; Young Adult | 2009 |
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytarabine; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neutropenia; Piperazines; Polyethylene Glycols; Proto-Oncogene Proteins c-abl; Pyrimidines; Recombinant Proteins; Remission Induction; RNA, Neoplasm; Stem Cells; Survival Analysis; Thrombocytopenia; Transcription, Genetic; Treatment Outcome | 2010 |
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome | 2007 |
Rapid control of chronic granulocytic leukaemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Hepatomegaly; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Remission Induction; Splenomegaly; Time Factors | 1993 |
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Hypertriglyceridemia; Infections; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Thrombocytopenia; Tretinoin | 2000 |
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anemia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Male; Middle Aged; Nausea; Prednisone; Time Factors; Vincristine; Vomiting | 1974 |
31 other study(ies) available for cytarabine and Anemia
| Article | Year |
|---|---|
A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Topics: Anemia; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Daunorubicin; Fatigue; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Lost to Follow-Up; Muscle Weakness; Thrombocytopenia; Young Adult | 2018 |
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Hypoalbuminemia; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Risk Factors; Rituximab; Singapore; Transplantation, Autologous | 2021 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Complete disappearance of ABO antigen-a cause of ABO discrepancy.
Topics: ABO Blood-Group System; Adolescent; Agglutination Tests; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Group Incompatibility; Blood Grouping and Crossmatching; Coombs Test; Cytarabine; Daunorubicin; Erythrocyte Transfusion; Fatal Outcome; Female; Humans; Leukemia, Erythroblastic, Acute; Oligosaccharides; Oligosaccharides, Branched-Chain; Plant Lectins; Platelet Transfusion; Sepsis | 2018 |
Abnormal erythroid cell proliferation and myelofibrosis in a cat.
Topics: Anemia; Animals; Cat Diseases; Cats; Cell Proliferation; Cytarabine; Erythroid Cells; Fatal Outcome; Myelodysplastic Syndromes; Primary Myelofibrosis | 2012 |
Anti-angiogenic activity of the purine analog 6-thioguanine.
Topics: 2-Aminopurine; Acute Disease; Aged; Allantois; Anemia; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cattle; Cell Line, Transformed; Chick Embryo; Chorion; Cytarabine; Daunorubicin; Drug Evaluation; Endothelial Growth Factors; Endothelium, Vascular; Etoposide; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymphokines; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neovascularization, Pathologic; Neovascularization, Physiologic; Remission Induction; Stress, Mechanical; Thioguanine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Severe immune haemolysis in a group A recipient of a group O red blood cell unit.
Topics: ABO Blood-Group System; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Blood Group Incompatibility; Cisplatin; Cytarabine; Dexamethasone; Erythrocyte Transfusion; Fever; Hemolysis; Humans; Immunization, Passive; Isoantibodies; Jaundice; Lymphoma, Non-Hodgkin; Male; Oligosaccharides; Oligosaccharides, Branched-Chain; Pain | 2003 |
Quantitative analysis of chromosomal G-bands in human hematopoietic disorders by methotrexate synchronization technique.
Topics: Anemia; Bone Marrow; Cell Cycle; Chromosome Aberrations; Chromosome Banding; Chromosome Disorders; Cytarabine; Hematologic Diseases; Humans; Karyotyping; Kinetics; Leukemia; Metaphase; Methotrexate | 1984 |
Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia.
Topics: Adult; Aged; Anemia; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Myeloproliferative Disorders; Preleukemia | 1983 |
Cytotoxic reduction and regeneration of murine marrow stem cells.
Topics: Anemia; Animals; Bone Regeneration; Colony-Forming Units Assay; Cytarabine; Female; Hematopoietic Stem Cells; Lymphocytes; Macrophages; Megakaryocytes; Mice; Regeneration; Tibia | 1983 |
Adriamycin-induced delayed erythropoietic injury expressed following anemia stress.
Topics: Anemia; Animals; Body Weight; Bone Marrow; Cytarabine; Doxorubicin; Erythropoiesis; Female; Femur; Iron; Mice; Organ Size; Spleen | 1980 |
[Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside].
Topics: Aged; Anemia; Cytarabine; Female; Humans; Leukemia; Leukopenia; Remission Induction | 1995 |
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome | 1994 |
Pseudomonas aeruginosa orbital phlegmon in a patient treated for myelodysplastic syndrome with concomitant Sjögren's syndrome.
Topics: Aged; Anemia; Cytarabine; Eye Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukopenia; Myelodysplastic Syndromes; Orbital Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Sjogren's Syndrome; Tomography, X-Ray Computed | 1999 |
[Acute leukemia in Jehovah's Witnesses].
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Christianity; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Fatal Outcome; Female; Humans; Male; Mercaptopurine; Methotrexate; Personnel, Hospital; Physician-Patient Relations; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Refusal to Treat; Remission Induction; Right to Die; Treatment Refusal; Vincristine | 1999 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2000 |
Treating acute nonlymphocytic leukemia.
Topics: Acute Disease; Aged; Anemia; Antineoplastic Agents; Bacterial Infections; Blood Transfusion; Cytarabine; Drug Therapy, Combination; Hemorrhage; Humans; Leukemia; Middle Aged; Mycoses; Remission, Spontaneous | 1978 |
[A patient with anemia].
Topics: Aged; Anemia; Blood Cell Count; Bone Marrow Examination; Cytarabine; Diagnosis, Differential; Female; Humans; Leukemia, Myeloid, Acute; Primary Myelofibrosis; Thioguanine | 1976 |
Serum immunoreactive erythropoietin in children with acute leukaemia at various stages of disease--and the effects of treatment.
Topics: Adolescent; Anemia; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Erythropoietin; Female; Hemoglobins; Humans; Infant; Leukemia, Myeloid, Acute; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Hb F production in stressed erythropoiesis: observations and kinetic models.
Topics: Anemia; Animals; Azacitidine; Cell Cycle; Cell Differentiation; Cytarabine; Erythropoiesis; Fetal Hemoglobin; Hematopoietic Stem Cells; Humans; Hydroxyurea; Kinetics; Models, Biological; Time Factors; Transcription, Genetic | 1985 |
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting | 1974 |
Daunorubicin. Results in childhood leukaemia.
Topics: Adolescent; Agranulocytosis; Anemia; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Female; Hemorrhage; Humans; Infant; Injections, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mercaptopurine; Neutrophils; Prednisolone; Thrombocytopenia; Vincristine | 1972 |
Decreased leukocyte alkaline phosphatase in monocytic leukemia.
Topics: Aged; Alkaline Phosphatase; Anemia; Blood Transfusion; Bone Marrow; Busulfan; Cytarabine; Female; Histocytochemistry; Humans; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Pneumonia; Purpura; Radiography; Sepsis; Splenomegaly; Staphylococcal Infections; Tetracycline; Thioguanine | 1972 |
Adult acute leukaemia--a suitable case for treatment?
Topics: Acute Disease; Adult; Aged; Agranulocytosis; Anemia; Blood Platelet Disorders; Blood Transfusion; Bone Marrow Diseases; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Mouth Diseases; Ulcer | 1973 |
Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anemia; Child; Cytarabine; DNA, Neoplasm; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Muramidase; Nausea; Remission, Spontaneous; Sex Factors; Thioguanine; Thrombocytopenia; Time Factors; Vomiting | 1974 |
Identification of circulating micromegakaryocytes in a case of refractory anemia: an electron microscopic-cytochemical study.
Topics: Adult; Alkaline Phosphatase; Anemia; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Cytarabine; Daunorubicin; Female; Histocytochemistry; Humans; Megakaryocytes; Microscopy, Electron; Microscopy, Phase-Contrast; Peroxidases; Thrombocytopenia | 1972 |
Cytosine arabinoside (NSC-63878) in the treatment of epidermoid carcinomas of the head and neck.
Topics: Adult; Aged; Anemia; Blood Cell Count; Carcinoma, Squamous Cell; Cytarabine; Head; Head and Neck Neoplasms; Humans; Leukopenia; Liver Function Tests; Male; Middle Aged; Thrombocytopenia; Time Factors | 1971 |
Treatment of AGL.
Topics: Adult; Afibrinogenemia; Aged; Anemia; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Humans; Hydroxyzine; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Mercaptopurine; Methotrexate; Middle Aged; Polycythemia Vera; Prednisone; Primary Myelofibrosis; Splenomegaly; Vincristine | 1969 |
[Cytosine arabinoside in the treatment of advanced lymphoblastic leukemia in children].
Topics: Adolescent; Anemia; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia, Lymphoid; Thrombocytopenia | 1969 |
Cytarabine.
Topics: Acute Disease; Amino Sugars; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cyclophosphamide; Cytarabine; Glycosides; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Vincristine | 1971 |
Adaptation of hemopoietic systems to environmental conditions.
Topics: Adaptation, Physiological; Anemia; Animals; Bone Marrow; Cell Division; Cytarabine; Environment; Environmental Exposure; Erythrocytes; Erythropoietin; Hematopoiesis; Hematopoietic Stem Cells; Hematopoietic System; Hypoxia; Iron Isotopes; Methotrexate; Mice; Mitosis; Phenylhydrazines; Rats | 1970 |